Predictions
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€26.40
12.10.21
12.10.21
€29.00
12.10.22
12.10.22
-15.27%
13.10.22
13.10.22
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.44
12.10.21
12.10.21
-
12.10.22
12.10.22
7.38%
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
NRX Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.20
12.10.21
12.10.21
-
12.10.22
12.10.22
39.52%
17.10.21
17.10.21
Risky Investment
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€56.70
12.10.21
12.10.21
-
12.10.22
12.10.22
14.20%
13.10.22
13.10.22
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€56.40
12.10.21
12.10.21
-
12.10.22
12.10.22
10.82%
12.10.22
12.10.22
Radius Health Inc.
Start price
Target price
Perf. (%)
€12.84
11.10.21
11.10.21
€20.00
31.12.23
31.12.23
-18.07%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
ReShape Lifesciences Inc.
Start price
Target price
Perf. (%)
-
11.10.21
11.10.21
€5.00
11.10.22
11.10.22
0.00%
18.10.21
18.10.21
Could be very worthwhile Investment >20% year
Appharvest Inc.
Start price
Target price
Perf. (%)
€4.84
11.10.21
11.10.21
€4.00
11.10.22
11.10.22
-5.37%
14.03.22
14.03.22
Could be worthwhile Investment >10% per year
Fair valuation
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Columbia Care Inc.
Start price
Target price
Perf. (%)
€3.26
11.10.21
11.10.21
€1.40
11.10.22
11.10.22
-34.05%
27.08.22
27.08.22
Capable Management
Innovative
Bad rating
Few uniques
Carbios S.A.
Start price
Target price
Perf. (%)
€39.68
11.10.21
11.10.21
€33.60
11.10.22
11.10.22
-34.73%
20.09.22
20.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Hexagon Purus As
Start price
Target price
Perf. (%)
€2.65
11.10.21
11.10.21
€2.00
11.10.22
11.10.22
-30.55%
12.10.22
12.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
SMA Solar Technology AG
Start price
Target price
Perf. (%)
€36.16
11.10.21
11.10.21
€50.00
11.10.22
11.10.22
14.49%
12.10.22
12.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Exela Technologies Inc.
Start price
Target price
Perf. (%)
€5,820.0
11.10.21
11.10.21
-
11.10.22
11.10.22
0.34%
15.10.21
15.10.21
Risky Investment
AEHR Test Systems
Start price
Target price
Perf. (%)
€15.60
11.10.21
11.10.21
-
04.10.22
04.10.22
-5.86%
05.10.22
05.10.22
Revenue growth >5% per year expected
Top 10 in its market
Probably not worthwhile Investment
Little known brand
Marvell Technology Inc.
Start price
Target price
Perf. (%)
€56.04
10.10.21
10.10.21
€41.00
19.12.21
19.12.21
33.83%
20.12.21
20.12.21
Could be worthwhile Investment >10% per year
UMC Electronics Co Ltd
Start price
Target price
Perf. (%)
€4.96
10.10.21
10.10.21
€7.00
10.10.22
10.10.22
-42.74%
08.04.22
08.04.22
Could be worthwhile Investment >10% per year